Canadian biopharmaceutical company: Acasti Pharma (ACST) (2002)

Acasti Pharma Inc. (NASDAQ:ACST) was founded in 2002 and is headquartered in Laval, Canada. It has 7 full-time employees. It is a biopharmaceutical company focusing on the research, development and commercialization of drugs for various cardiometabolic disorders caused by abnormal blood lipids. application.

Acasti Pharma Inc ACST Logo

Acasti Pharma (ACST):

Acasti Pharma Inc. is a biopharmaceutical company specializing in cardiovascular diseases. It is a subsidiary of Neptune Technologies & Bioressources Inc.. Acasti Pharma’s drugs Onemia and CaPre are mainly used to treat and prevent cardiovascular and metabolic diseases.

  1. Onemia-a medical food (diet therapy), mainly for the dietary management of patients with omega-3 phospholipid deficiency, and related dyslipidemia and cardiometabolic diseases;
  2. CaPre-the company’s prescription drug candidate product, omega-3 phospholipid therapy, is mainly used for the prevention and treatment of cardiovascular and metabolic disorders, including hypertriglyceridemia. It is currently in phase III clinical trials for the treatment of hypertriglyceridemia.
Notify of
Inline Feedbacks
View all Intels

REIT company: American Assets Trust (AAT) (1967)

Emergency Room & Nursing Service Company: Adeptus Health (ADPT)-Delisting (2002)